At the School of Optometry & Vision Science we're shaping the future of vision through our research and innovative product development.
From corneal disease to using the eye to monitor tear neuropeptides, the School of Optometry & Vision Science is at the forefront of vision research. We strive to continually address vision problems affecting everyday Australians. Our research excellence embodies a multidisciplinary, evidence-based approach.
Dry eye disease - commonly prevalent in Asian populations and poorly managed - highlights the importance of loss of tear film homeostasis and neurosensory abnormalities. In this research program, a suite of techniques and instruments focused on these two key disease processes has been developed and validated.
This research aims to develop quorum-sensing inhibitors and antimicrobial peptides and mimics and incorporating them into polymers and biomaterials with the objective of reducing infection associated with devices.
This research provides improved strategies for improving compliance with medical devices and patient involvement in research, as well as expertise in genomics, immunology, microbiology, image analysis, and mathematical modelling to improve diagnosis and treatment of corneal infections.
The Public Health Research Group has demonstrated its ability to convene multidisciplinary teams to address priority issues in injury prevention and eye health for people with age related eye disease.
Diabetic neuropathy needs to be diagnosed and monitored early, especially in remote locations without access to specialty care. Early diagnosis and prevention of complications may be possible through monitoring tear neuropeptides.